Comparing Ormeloxifene With Norethisterone In Treatment For Uterine Bleeding Without Any Organic Cause
Not Applicable
- Conditions
- Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified
- Registration Number
- CTRI/2020/06/025630
- Lead Sponsor
- Dr Manogna Chukka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Females Having Complain Of Heavy Menstrual Blood Loss
Exclusion Criteria
1 Haemodynamically Unstable Patients
2 Organic Pelvic Pathology
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Both The Comparing Drugs Are Not Same In EfficacyTimepoint: My Period Of Study Is Of 18 Months
- Secondary Outcome Measures
Name Time Method nwanted Blood Loss Can Be Prevented, Eventually Reducing AnaemiaTimepoint: My Period Of Study Is Of 18 Months